288 related articles for article (PubMed ID: 25363869)
1. Pigment epithelium derived factor suppresses expression of Sost/Sclerostin by osteocytes: implication for its role in bone matrix mineralization.
Li F; Song N; Tombran-Tink J; Niyibizi C
J Cell Physiol; 2015 Jun; 230(6):1243-9. PubMed ID: 25363869
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/GSK-3beta/beta-catenin signaling.
Li F; Cain JD; Tombran-Tink J; Niyibizi C
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3449-3458. PubMed ID: 30076958
[TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo.
Li F; Cain JD; Tombran-Tink J; Niyibizi C
J Bone Miner Metab; 2019 Sep; 37(5):773-779. PubMed ID: 30607618
[TBL] [Abstract][Full Text] [Related]
4. Pigment epithelium-derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells.
Li F; Song N; Tombran-Tink J; Niyibizi C
Stem Cells; 2013 Dec; 31(12):2714-23. PubMed ID: 23939834
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium derived factor upregulates expression of vascular endothelial growth factor by human mesenchymal stem cells: Possible role in PEDF regulated matrix mineralization.
Li F; Armstrong GB; Tombran-Tink J; Niyibizi C
Biochem Biophys Res Commun; 2016 Sep; 478(3):1106-10. PubMed ID: 27530920
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade.
Belinsky GS; Sreekumar B; Andrejecsk JW; Saltzman WM; Gong J; Herzog RI; Lin S; Horsley V; Carpenter TO; Chung C
FASEB J; 2016 Aug; 30(8):2837-48. PubMed ID: 27127101
[TBL] [Abstract][Full Text] [Related]
8. Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro.
Jäger A; Götz W; Lossdörfer S; Rath-Deschner B
J Periodontal Res; 2010 Apr; 45(2):246-54. PubMed ID: 19778325
[TBL] [Abstract][Full Text] [Related]
9. Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt/β-catenin activity.
Abed É; Couchourel D; Delalandre A; Duval N; Pelletier JP; Martel-Pelletier J; Lajeunesse D
Bone; 2014 Feb; 59():28-36. PubMed ID: 24184155
[TBL] [Abstract][Full Text] [Related]
10. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium derived factor play a positive role in bone mineralization of osteoblasts derived from diabetic patients.
Song N; Zhong J; Zhang J; Yu J; Li J; Qi J; Yang J; Qiu Y; Su W; Feng Z; Wang H
Gene; 2017 Sep; 627():563-568. PubMed ID: 28698158
[TBL] [Abstract][Full Text] [Related]
12. A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor.
Farber CR; Reich A; Barnes AM; Becerra P; Rauch F; Cabral WA; Bae A; Quinlan A; Glorieux FH; Clemens TL; Marini JC
J Bone Miner Res; 2014 Jun; 29(6):1402-11. PubMed ID: 24519609
[TBL] [Abstract][Full Text] [Related]
13. Antagonism Between PEDF and TGF-β Contributes to Type VI Osteogenesis Imperfecta Bone and Vascular Pathogenesis.
Kang H; Aryal Ac S; Barnes AM; Martin A; David V; Crawford SE; Marini JC
J Bone Miner Res; 2022 May; 37(5):925-937. PubMed ID: 35258129
[TBL] [Abstract][Full Text] [Related]
14. Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content.
Gattu AK; Swenson ES; Iwakiri Y; Samuel VT; Troiano N; Berry R; Church CD; Rodeheffer MS; Carpenter TO; Chung C
FASEB J; 2013 Nov; 27(11):4384-94. PubMed ID: 23887690
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
[TBL] [Abstract][Full Text] [Related]
18. A mouse model for human osteogenesis imperfecta type VI.
Bogan R; Riddle RC; Li Z; Kumar S; Nandal A; Faugere MC; Boskey A; Crawford SE; Clemens TL
J Bone Miner Res; 2013 Jul; 28(7):1531-6. PubMed ID: 23413146
[TBL] [Abstract][Full Text] [Related]
19. The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization.
Fan W; Crawford R; Xiao Y
Differentiation; 2011 Mar; 81(3):181-91. PubMed ID: 21236558
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.
Lin C; Jiang X; Dai Z; Guo X; Weng T; Wang J; Li Y; Feng G; Gao X; He L
J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
